Policy & Regulation
SiteOne Therapeutics signs collaboration and licensing agreement with Vertex Pharmaceuticals
20 January 2022 - SiteOne Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, announced on Wednesday that it has signed a strategic collaboration and licensing agreement with Verte...
Lynk Pharmaceuticals doses first patient with LNK01001 in Phase II ankylosing spondylitis clinical trial
20 January 2022 - Lynk Pharmaceuticals Co. Ltd., a China-based clinical stage company, announced on Wednesday that it dosed the first patient with LNK01001 in its Phase II clinical trial aimed at anky...
ESSA Pharma doses first patient in Phase 1/2 study to assess EPI-7386 safety, tolerability and preliminary efficiency
20 January 2022 - ESSA Pharma Inc. (NASDAQ: EPIX), a Canada-based clinical-stage pharmaceutical company, announced on Wednesday that it has dosed the first patient in the company-sponsored Phase 1/2 s...
Research finds rapid antigen tests for COVID-19 may be unreliable in children
20 January 2022 - New research has found that rapid antigen tests used in children for detecting COVID-19 do not meet accuracy criteria set by the World Health Organization and US and UK device regula...
Seegene to unveil the new COVID-19 PCR test with reduced turnaround time of one hour for mass testing
20 January 2022 - Diagnostics company Seegene Inc (KQ 096530) stated on Wednesday that it plans to introduce the Allplex SARS-CoV-2 Fast PCR Assay that can deliver PCR results in just 60 minutes in la...
Novavax Inc's Nuvaxovid first protein-based COVID-19 vaccine receives approval for provisional registration in Australia
20 January 2022 - Biotechnology company Novavax Inc (Nasdaq:NVAX) reported on Wednesday the receipt of approval from Australia's Therapeutic Goods Administration (TGA) for provisional registratio...